Finland, Jan. 29 -- Finland based Ascendis Pharma A/S has secured contract from HUS Group, the joint authority for Helsinki and Uusimaa for Pharmaceutical products - Palopegteriparatidivalmisteen (Yorvipath) hankinta. The value of the contract is worth 76000000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....